Breast Cancer

Personalized management of hormone receptor-positive (HR+), HER2-enriched, and Triple-Negative Breast Cancer (TNBC) utilizing CDK4/6 inhibitors, targeted antibody-drug conjugates, and evidence-based chemotherapy.

Ovarian Cancer

Comprehensive medical oncology care for high-grade serous, clear cell, and endometrioid ovarian cancers, featuring platinum-based chemotherapy, bevacizumab angiogenesis inhibition, and BRCA/HRD-directed PARP maintenance.

Cervical Cancer

Specialized systemic regimens for squamous cell and adenocarcinoma of the cervix, combining concurrent radiosensitizing cisplatin, targeted VEGF inhibition, and immune checkpoint blockade.

Blood Cancer

Expert management of haematological malignancies including Acute/Chronic Leukemias, Hodgkin & Non-Hodgkin Lymphomas, and Multiple Myeloma through targeted immunochemotherapy and transplant coordination.

Lung Cancer

Comprehensive next-generation sequencing driven targeted therapy (EGFR, ALK, ROS1, KRAS G12C, MET, RET) and frontline chemo-immunotherapy protocols for thoracic and lung malignancies.

Second Opinions

Independent, thorough clinical re-evaluation of pathology slides, PET-CT staging, and proposed therapeutic strategies by a European Certified Medical Oncologist (ECMO) ensuring total confidence.

Oncology Second Opinion

Seeking an Expert Clinical Evaluation?

Connect with Dr. Chinmayee Agrawal for biopsy review, precision genomic mutation assessment, and evidence-based cancer management plans.